AI integrations with lung cancer screening: Considerations in developing AI in a public health setting.

Journal: European journal of cancer (Oxford, England : 1990)
Published Date:

Abstract

Lung cancer screening implementation has led to expanded imaging of the chest in older, tobacco-exposed populations. Growing numbers of screening cases are also found to have CT-detectable emphysema or elevated levels of coronary calcium, indicating the presence of coronary artery disease. Early interventions based on these additional findings, especially with coronary calcium, are emerging and follow established protocols. Given the pace of diagnostic innovation and the potential public health impact, it is timely to review issues in developing useful chest CT screening infrastructure as chest CT screening will soon involve millions of participants worldwide. Lung cancer screening succeeds because it detects curable, early primary lung cancer by characterizing and measuring changes in non-calcified, lung nodules in the size-range from 3mm to 15 mm in diameter. Therefore, close attention to imaging methodology is essential to lung screening success and similar image quality issues are required for reliable quantitative characterization of early emphysema and coronary artery disease. Today's emergence of advanced image analysis using artificial intelligence (AI) is disrupting many aspects of medical imaging including chest CT screening. Given these emerging technological and volume trends, a major concern is how to balance the diverse needs of parties committed to building AI tools for precise, reproducible, and economical chest CT screening, while addressing the public health needs of screening participants receiving this service. A new consortium, the Alliance for Global Implementation of Lung and Cardiac Early Disease Detection and Treatment (AGILE) is committed to facilitate broad, equitable implementation of multi-disciplinary, high quality chest CT screening using advanced computational tools at accessible cost.

Authors

  • James L Mulshine
    Internal Medicine, Graduate College, Rush University Medical Center, Chicago, Illinois.
  • Ricardo S Avila
    Accumetra, LLC, Clifton Park, NY, USA. Electronic address: rick.avila@accumetra.com.
  • Mario Silva
    Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Carolyn Aldige
    Prevent Cancer Foundation, Alexandria, VA, USA. Electronic address: Caroline.aldige@pcfounder.org.
  • Torsten Blum
    The Helios Klinikum Emil von Behring, Berlin, Germany. Electronic address: Torsten-gerriet.blum@helios-gesundheit.de.
  • Matthew Cham
    Department of Radiology, University of Washington, Seattle, WA, USA. Electronic address: mdcham@uw.edu.
  • Harry J de Koning
  • Sean B Fain
    From the Departments of Medical Physics, Radiology, and Biomedical Engineering, University of Wisconsin-Madison, 1111 Highland Ave, Madison, WI 53705.
  • John Field
    Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK. Electronic address: j.k.field@liverpool.ac.uk.
  • Raja Flores
    Mount Sinai Health System, New York, NY, USA. Electronic address: raja.flores@mountsinai.org.
  • Maryellen L Giger
    Department of Radiology, University of Chicago, 5841 S Maryland Ave., Chicago, IL, 60637, USA.
  • Ilya Gipp
    General Electric Healthcare, Atlanta, GA, USA. Electronic address: ilya.gippe@gehealthcare.com.
  • Frederic W Grannis
    City of Hope Medical Center, Duarte, CA, USA. Electronic address: fgrannis@coh.org.
  • Jan Willem C Gratama
  • Cheryl Healton
    School of Global Public Health, New York University, New York, USA. Electronic address: Cheryl.healton@nyu.edu.
  • Ella A Kazerooni
    Departments of Radiology & Internal Medicine, University of Michigan Medical School, Michigan, MI, USA.
  • Karen Kelly
    International Association for the Study of Lung Cancer, Denver, CO, USA. Electronic address: karen.kelly@iaslc.org.
  • Harriet L Lancaster
    Institute for Diagnostic Accuracy, Groningen, the Netherlands; University of Groningen, University Medical Center Groningen, Department of Epidemiology, Groningen, the Netherlands.
  • Luis M Montuenga
    Universidad de Navarre, CIMA, CIBERONC and IdisNa, Pamplona, Spain. Electronic address: lmontuenga@unav.es.
  • Kyle J Myers
    Division of Imaging, Diagnostics, and Software Reliability, Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, Food and Drug Administration (FDA), Silver Spring, MD, USA.
  • Morteza Naghavi
    2 Society for Heart Attack Prevention and Eradication Palo Alto CA.
  • Raymond Osarogiagbon
    Baptist Cancer Center, Memphis, TN, USA. Electronic address: Raymond.Osarogiagbon@bmg.md.
  • Ugo Pastorino
    Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
  • Bruce S Pyenson
    Milliman, Inc, New York, NY, USA. Electronic address: bruce.pyenson@milliman.com.
  • Anthony P Reeves
    Department of Electrical and Computer Engineering, Cornell University, Ithaca.
  • Albert Rizzo
    USC Institute of Creative Technologies, Playa Vista, California, USA.
  • Sheila Ross
    I-ELCAP Board, Annapolis, MD, USA. Electronic address: sheilamross@mac.com.
  • Victoria Schneider
    Siemens Healthineers, Erlangen, Germany. Electronic address: Victoria.schneider@siemens-healthineers.com.
  • Luis M Seijo
    Clínica Universidad de Navarra, Pamplona, Spain.
  • Dorith Shaham
    Department of Medical Imaging, Hadassah Medical Center, Jerusalem, Israel.
  • Robert Smith
    American Cancer Society, Atlanta, GA, USA. Electronic address: robert.smith@cancer.org.
  • Emanuela Taoli
    Mount Sinai Health System, New York, NY, USA. Electronic address: emanuela.taioli@mountsinai.org.
  • Kevin Ten Haaf
    Department of Public Health, Erasmus Medical Center, University Medical Center Rotterdam, Rotterdam, the Netherlands. Electronic address: k.tenhaaf@erasmus.nl.
  • Carlijn M van der Aalst
  • Lucia Viola
    Internal Medicine, Fundación Neumológica, Colombiana, Bogotá, Colombia. Electronic address: lviola@neumologica.org.
  • Jens Vogel-Claussen
    Institute of Diagnostic and Interventional Radiology Hannover Medical School Hannover Germany.
  • Anna N H Walstra
    Institute for Diagnostic Accuracy, Groningen, the Netherlands.
  • Ning Wu
    Department of Chemical and Biological Engineering, Colorado School of Mines, Golden, Colorado, USA 80401.
  • Pan-Chyr Yang
    National Taiwan University, Taipei, Taiwan. Electronic address: pcyang@ntu.edu.tw.
  • Rowena Yip
    Department of Radiology, Icahn School of Medicine at Mount Sinai, New York.
  • Matthijs Oudkerk
    University Medical Center, Groningen, The Netherlands.
  • Claudia I Henschke
    Department of Radiology, Icahn School of Medicine at Mount Sinai, New York.
  • David F Yankelelvitz
    Mount Sinai Health System, New York, NY, USA. Electronic address: david.yankelevitz@mountsinai.org.